Comparing PCR Tests for Epstein-Barr Virus DNA in Blood
Author Information
Author(s): Francesca Perandin, Elisabetta Cariani, Caterina Patrizia Pollara, Nino Manca
Primary Institution: Department of Experimental and Applied Medicine, Section of Microbiology, University of Brescia
Hypothesis
The study aims to compare the performance of two real-time PCR assays for quantifying Epstein-Barr virus (EBV) DNA in plasma.
Conclusion
Both the commercial and the in-house assay may be appropriate for clinical use, but common standards are advisable for comparable absolute values.
Supporting Evidence
- The clinical sensitivity of Q-EBV PCR was higher for samples with less than 1,000 EBV DNA copies/ml.
- Both assays showed statistically correlated results (R2 = 0.7789; p < 0.0001).
- 17 out of 199 plasma samples were positive for EBV DNA by both methods.
Takeaway
The study looked at two tests to measure a virus in blood and found they work similarly, but using the same standards would help make the results clearer.
Methodology
The study compared two real-time PCR assays using 199 plasma samples, evaluating their sensitivity, linearity, and precision.
Potential Biases
Potential bias due to differences in PCR efficiency between the assays.
Limitations
The study did not address the variability in EBV DNA load detected by different assays.
Participant Demographics
199 consecutive plasma samples received for EBV DNA quantification, including samples from healthy blood donors.
Statistical Information
P-Value
p<0.0001
Statistical Significance
p<0.0001
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website